Dramatic Response of Nail Psoriasis to Infliximab

Dramatic Response of Nail Psoriasis to Infliximab

Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress. Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotre...

Full description

Bibliographic Details
Main Authors: Safa, Gilles, Darrieux, Laure
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099188/
id pubmed-3099188
recordtype oai_dc
spelling pubmed-30991882011-05-31 Dramatic Response of Nail Psoriasis to Infliximab Safa, Gilles Darrieux, Laure Case Report Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress. Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotrexate, and cyclosporin, can be time-consuming, painful, or limited by significant toxicities. Biological agents may have the potential to revolutionize the management of patients with disabling nail psoriasis. We present another case of disabling nail psoriasis that responded dramatically to infliximab. Hindawi Publishing Corporation 2011 2011-05-10 /pmc/articles/PMC3099188/ /pubmed/21629846 http://dx.doi.org/10.1155/2011/107928 Text en Copyright © 2011 G. Safa and L. Darrieux. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Safa, Gilles
Darrieux, Laure
spellingShingle Safa, Gilles
Darrieux, Laure
Dramatic Response of Nail Psoriasis to Infliximab
author_facet Safa, Gilles
Darrieux, Laure
author_sort Safa, Gilles
title Dramatic Response of Nail Psoriasis to Infliximab
title_short Dramatic Response of Nail Psoriasis to Infliximab
title_full Dramatic Response of Nail Psoriasis to Infliximab
title_fullStr Dramatic Response of Nail Psoriasis to Infliximab
title_full_unstemmed Dramatic Response of Nail Psoriasis to Infliximab
title_sort dramatic response of nail psoriasis to infliximab
description Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress. Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotrexate, and cyclosporin, can be time-consuming, painful, or limited by significant toxicities. Biological agents may have the potential to revolutionize the management of patients with disabling nail psoriasis. We present another case of disabling nail psoriasis that responded dramatically to infliximab.
publisher Hindawi Publishing Corporation
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099188/
_version_ 1611455010751643648

Similar Items